IRVINE, Calif., May 29 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. , today announced it will present at the FTN Midwest Health Care Conference at 2:30 p.m. Eastern Time on Tuesday, June 5, at The Four Seasons Hotel in New York.
ISTA's Chief Financial Officer and Vice President of Corporate Development, Lauren Silvernail, will provide an update on the Company's commercial and clinical progress. To access the live audio broadcast or the subsequent archived recording log onto http://www.istavision.com. Please connect to the website several minutes prior to the start of the conference call to ensure adequate time for any software download that may be necessary.
ABOUT ISTA PHARMACEUTICALS
ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's products and product candidates addressing the $3.2 billion U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, dry eye, and vitreous hemorrhage. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share. The Company's product development and commercialization strategy is to launch a new product every 12 to 18 months, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.
ISTA Pharmaceuticals, Inc.CONTACT: Vince Anido, +1-949-788-5311, vanido@istavision.com, or LaurenSilvernail, +1-949-788-5302, lsilvernail@istavision.com, both of ISTAPharmaceuticals; Jason Farber - Media, jfarber@burnsmc.com, or JulianeSnowden-Andrew - Investors, jsnowden-andrew@burnsmc.com, +1-212-213-0006,both of Burns McClellan for ISTA Pharmaceuticals
Web site: http://www.istavision.com/
